<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04693000</url>
  </required_header>
  <id_info>
    <org_study_id>BSMMU/2019/10655</org_study_id>
    <nct_id>NCT04693000</nct_id>
  </id_info>
  <brief_title>Use of Topical Solasodine of Solanum Melongena Peel Origin in the Treatment of Palmar Arsenic Keratosis</brief_title>
  <official_title>Use of Topical Solasodine of Solanum Melongena Peel Origin in the Treatment of Palmar Arsenic Keratosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Arsenic is one of the largest mass poisonings in Bangladesh. Arsenic keratosis of the palm&#xD;
      and sole is a common feature of arsenicosis. Brinjal or eggplant ubiquitous vegetable found&#xD;
      in different parts of the world, including Bangladesh, scientifically known as Solanum&#xD;
      melongena. A study showed ointment containing crude extract of Solanum melongena peel origin&#xD;
      is effective in arsenic keratosis. Solasodine is one of the active compounds of Solanum&#xD;
      melongena peel. In the current study, an ointment containing a single compound solasodine&#xD;
      isolated from Solanum melongena peel . The ointment made from solasodine extract was&#xD;
      distributed among arsenic keratosis patients to see the effect.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      About millions of Bangladeshi people are chronically exposed to high arsenic concentrations&#xD;
      (above 50 micrograms/liter) through contaminated drinking water and thus suffer from&#xD;
      arsenic-related health hazards called arsenicosis. Arsenic keratosis is one of the commonest&#xD;
      skin manifestations of arsenicosis that occur in the palm and sole that is troublesome for&#xD;
      the working people and females suffered a negative socio-economic impact.&#xD;
&#xD;
      Two studies were conducted in the same department where topical ointment prepared from the&#xD;
      crude extract of S. melongena peel was found effective in arsenical keratosis.&#xD;
&#xD;
      The present study was conducted to confirm the previous study and identify that solasodine&#xD;
      isolated from S. melongena peel is responsible for the cure of the lesions of arsenical&#xD;
      keratosis. Thus, it may be possible for the chemical synthesis of solasodine, and an&#xD;
      effective, inexpensive topical ointment can be prepared for the cure of arsenical keratosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 23, 2018</start_date>
  <completion_date type="Anticipated">January 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 15, 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Arsenical Keratotic nodular size of the palm</measure>
    <time_frame>12 weeks</time_frame>
    <description>Keratotic nodular size or lesion size will be measured by slide calipers</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Keratotic Nodular Size</condition>
  <arm_group>
    <arm_group_label>Keratosis lesion or nodular size observation after 12 weeks of therapy with solasodine ointment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>An ointment containing solasodine extract of solanum melongena peel origin applied to patients with palmar arsenical keratosis; dose-twice daily for 12 weeks.&#xD;
Keratotic nodular size observation after 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Arsenic Keratosis lesion or nodular size observation after 12 weeks of therapy with solasodine ointment</intervention_name>
    <description>An ointment containing solasodine extract of solanum melongena peel origin applied to patients with palmar arsenical keratosis; dose-twice daily for 12 weeks.Keratotic nodular size observation after 12 weeks</description>
    <arm_group_label>Keratosis lesion or nodular size observation after 12 weeks of therapy with solasodine ointment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Presence of moderate to severe palmar arsenical keratosis&#xD;
&#xD;
          -  Drinking arsenic-contaminated water for at least six months&#xD;
&#xD;
          -  Patient voluntarily agreed to participate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age less than 18 years or more than 60 years&#xD;
&#xD;
          -  Pregnant and nursing mother&#xD;
&#xD;
          -  Skin diseases like atopic dermatitis eczema and psoriasis&#xD;
&#xD;
          -  Patient allergic to brinjal (eggplant)&#xD;
&#xD;
          -  Patient taken any treatment of arsenicosis for the last six months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Muradnagar Upazilla</name>
      <address>
        <city>Comilla</city>
        <zip>3540</zip>
        <country>Bangladesh</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bangladesh</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 30, 2020</study_first_submitted>
  <study_first_submitted_qc>December 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 5, 2021</study_first_posted>
  <last_update_submitted>December 31, 2020</last_update_submitted>
  <last_update_submitted_qc>December 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh</investigator_affiliation>
    <investigator_full_name>Dr Mohammad Sazzad Hossain</investigator_full_name>
    <investigator_title>MBBS, MD(Phase B) Resident</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

